PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma. (Q52431428)

1 May 2018

title

PIK3CA and KRAS mutations in cell free circulating DNA are useful markers for monitoring ovarian clear cell carcinoma. (English)

1 reference

1 May 2018

author name string

Asuka Morikawa

1

1 reference

1 May 2018

Tomoatsu Hayashi

2

1 reference

1 May 2018

Naomi Shimizu

3

1 reference

1 May 2018

Mana Kobayashi

4

1 reference

1 May 2018

Kenzui Taniue

5

1 reference

1 May 2018

Akiko Takahashi

6

1 reference

1 May 2018

Kota Tachibana

7

1 reference

1 May 2018

Misato Saito

8

1 reference

1 May 2018

Ayako Kawabata

9

1 reference

1 May 2018

Yasushi Iida

10

1 reference

1 May 2018

Kazu Ueda

11

1 reference

1 May 2018

Motoaki Saito

12

1 reference

1 May 2018

Nozomu Yanaihara

13

1 reference

1 May 2018

Hiroshi Tanabe

14

1 reference

1 May 2018

Kyosuke Yamada

15

1 reference

1 May 2018

Hirokuni Takano

16

1 reference

1 May 2018

Osamu Nureki

17

1 reference

1 May 2018

Aikou Okamoto

18

1 reference

1 May 2018

Tetsu Akiyama

19

1 reference

1 May 2018

language of work or name

English

0 references

publication date

22 February 2018

1 reference

1 May 2018

published in

Oncotarget

1 reference

1 May 2018

volume

9

1 reference

1 May 2018

page(s)

15266-15274

1 reference

1 May 2018

issue

20

1 reference

1 May 2018

Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Clinical significance of monitoring ESR1 mutations in circulating cell-free DNA in estrogen receptor positive breast cancer patients.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Analysis of circulating tumor DNA to monitor metastatic breast cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Cell-free nucleic acids as biomarkers in cancer patients

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Isolation and characterization of DNA from the plasma of cancer patients

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.

13 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5880602

Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients

13 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29632642

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.24555

1 reference

1 May 2018

PMCID

5880602

1 reference

1 May 2018

PubMed ID

29632642

1 reference

1 May 2018